We are transforming global healthcare from a reactive system of treating sickness to a proactive discipline of preserving health.
Current medicine is built on a fundamental flaw: we wait for the fire to spread before calling the firefighters. We treat symptom clusters, not root causes. Our Founder's 37-year diagnostic odyssey revealed the system's failure—and the three critical gaps we now exist to close:
Cytoverse integrates single-cell multi-omics, population genomics, and functional data to create a unified "coordinate system" of health. It learns a disentangled representation of disease axes, allowing each individual to be projected and tracked on a continuous map of human health.
Cytoscope enables continuous tracking of multivariate biomarkers to triangulate health states. Unlike fixed, affinity-based sensors, our programmable, multi-modal spectroscopy can be updated in real-time to track biomarkers relevant to your emerging risk profile.
Cytonome is a privacy-first agent that performs local fine-tuning on your device. It formulates hypotheses based on Cytoscope data and engages you in dialogue to gather missing lifestyle context. By integrating "soft" phenotypic data with "hard" molecular evidence, it suggests causal interventions to revert pathological trajectories.
Building the core infrastructure. We are developing the Neuroverse and Immunoverse models, aggregating 10M+ cells of multi-omics data, and validating our programmable sensor technology in vitro.
From research to reality. We will launch direct-to-consumer pilots, achieve FDA clearances for autoimmune and mental health panels, and demonstrate clinical efficacy in longitudinal cohorts.
Universal access. We will deploy in emerging markets with subsidized pricing models, ensuring the geography lottery no longer dictates health outcomes.
For centuries, humanity faced a false choice: pursue profit or pursue purpose. The Helix Framework reveals this dichotomy as an illusion. Just as yin and yang are complementary aspects of a unified whole—each containing the seed of the other—profit and purpose are two strands of the same organizational DNA.
When structured correctly, profit amplifies purpose and purpose generates profit in an upward spiral of sustainable impact. The Cytognosis Foundation serves as the first comprehensive implementation, demonstrating how mission-locked organizations can attract substantial capital while maintaining unwavering commitment to global health equity.
"Capital is oxygen for moonshots—without it, transformative ideas suffocate before reaching the patients they could save. But here's the paradox: the moment money shifts from catalyst to purpose, we fail. True innovation emerges when mission alignment is encoded in our organizational DNA, as immutable as genetic code itself. Like the double helix, profit and purpose spiral upward together—neither can exist without the other, each stabilizing and propelling its complement."
— Shahin Mohammadi, Founder
Read more about the Helix Framework on our blog (coming soon).